In This Article:
For decades, companies and researchers have been exploring implantable devices that can make the physically impossible a reality. These devices have been game-changers for people like Rodney, a patient based in Australia who has amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. ALS gradually inhibits all movement, including your ability to communicate.
Rodney was able to communicate with me by using the Stentrode device: a tiny electrode that converts brain signals into physical actions. In other words, the device reads his mind, by allowing him to type without ever moving his hands.
The Stentrode was developed by Synchron, a neurotech company backed by Jeff Bezos and Bill Gates. And it’s only the beginning.
Tech companies like Meta (META) are building off neurotech advancements in the medical world, which could lead to more consumer facing neurotech products in the future.
If you’re going to future-proof your portfolio, you need to know what’s NEXT in the business of neurotechnology. In this series, Yahoo Finance will feature stories that give a glimpse at the future, and show how companies are making big moves today that will matter tomorrow.
Related Videos
For more on our NEXT series, click here, and tune in to Yahoo Finance Live for more expert insight and the latest market action, Monday through Friday.